Romero M and Pyle AD. “Enhancing” Skeletal Muscle and Stem Cells in 3D: Genome regulation of skeletal muscle in development and disease. Current Opinion in Genetics & Development 2023, 83:102133
Hicks MR #, Saleh KK, Clock B, Gibbs DE, Yang M, Younesi S, Gane L, Guiterez-Garcia V, Xi H, Pyle AD #. Regenerating Human Skeletal Muscle Forms an Emerging Niche In Vivo to Support PAX7 cells. Nature Cell Biology. November 2 2023. # co-corresponding
Hicks MR#, Liu X#, Young CS, Saleh K, Ji Y, Jiang, J, Emami MR, Mokhonova E, Spencer MJ*, Meng H*, Pyle AD*. Nanoparticles systemically biodistribute to regenerating skeletal muscle in DMD. Journal of Nanobiotechnology volume 21, Article number: 303 (2023). #co-first, * co-corresponding
Emami MR, Espinoza, Young CS, Ma F, Farahat PK, Felgner PL, Chamberlain JS, Xu X, Pyle AD, Pellegrini M, Villalta A and Spencer MJ. Innate and adaptive AAV-mediated immune responses in a mouse model of Duchenne muscular dystrophy. Molecular Therapy, Methods and Clinical Development, Jun 8, 2023.
Jaime OG, Arias J, Pavani S, Pyle AD, Hicks MR. SIX1+PAX3+ identify a progenitor for myogenic lineage commitment from hPSCs. Development. 2023 Jun 27:dev.201509. doi: 10.1242/dev.201509. Online ahead of print.
Stearns-Reider KM, Hicks MR, Hammond KG, Reynolds JC, Maity A, Kurmangaliyev YZ, Chin J, Stieg AZ, Geisse NA, Hohlbauch S, Kaemmer S, Schmitt LR, Pham TT, Yamauchi K, Novitch BG, Wollman R, Hansen KC, Pyle AD, Crosbie RH. Myoscaffolds reveal laminin scarring is detrimental for stem cell function while sarcospan induces compensatory fibrosis. NPJ Regen Med. 2023 Mar 15;8(1):16. doi: 10.1038/s41536-023-00287-2.
Muscle fusogens go viral for gene delivery to skeletal muscle. Cell. 2023 May 11;186(10):2041-2043. doi: 10.1016/j.cell.2023.04.021.
Saleh KK, Switzler C, Hicks MR, Gane L, Gibbs DE, Pyle AD. Duchenne muscular dystrophy disease severity impacts skeletal muscle progenitor cells systemic delivery. Front Physiol. 2023 May 9;14:1190524. doi: 10.3389/fphys.2023.1190524. eCollection 2023.